Kane Biotech Inc., a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections. It offers revyve, an antimicrobial wound gel; and shampoos, shampoo bars, and scalp detoxifiers under the DermaKB brand. The company is also developing coactiv+ Antimicrobial Surgical Hydrogel for use in surgical/acute wounds; coactiv+ Antimicrobial Wound Rinse for use in acute and chronic wounds; coactiv+ Antimicrobial Wound Gel Spray for use in acute, chronic wounds, and first and second degree burns; and DispersinB Hydrogel for prosthetic joint infection. Kane Biotech Inc. was incorporated in 2001 and is based in Winnipeg, Canada.
तुलना करने के लिए मीट्रिक्स | KNE | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधKNEपीअर्सक्षेत्र | |
---|---|---|---|---|
पी/ई अनुपात | −3.5x | −3.9x | −0.5x | |
PEG अनुपात | −0.02 | 0.03 | 0.00 | |
क़ीमत/बुक | −24.7x | 2.0x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 8.5x | 2.3x | 3.0x | |
अपसाइड (विश्लेषक लक्ष्य) | - | 163.3% | 56.6% | |
उचित मूल्य अपसाइड | अनलॉक करें | 8.3% | 10.1% | अनलॉक करें |